Microtubule‐binding region tau fragment tau368 as a biomarker of Alzheimer’s disease
Joel Simrén(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Wagner S. Brum(Universidade Federal do Rio Grande do Sul), Hlin Kvartsberg(University of Gothenburg), Fernando González‐Ortiz(Sahlgrenska University Hospital), Niklas Mattsson(Malmö University), Przemysław R. Kac(University of Gothenburg), Oskar Hansson(Eli Lilly (United States)), Thomas K. Karikari(University of Pittsburgh), Douglas Galasko(University of Minnesota), Emma Sjons(Sahlgrenska University Hospital), Denis S. Smirnov(University of California San Diego), Shorena Janelidze(Lund University), Nicholas J. Ashton(King's College London), Henrik Zetterberg(University of Wisconsin System), Sebastian Palmqvist(Skåne University Hospital)
Cited by 1
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k